These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 1986925)
1. Pharmaceutical research is expensive but well worth the cost. Mossinghoff GJ Endocrinology; 1991 Jan; 128(1):3-4. PubMed ID: 1986925 [No Abstract] [Full Text] [Related]
2. NIH urged to cap profits made on publicly funded research. Macilwain C Nature; 2000 Jul; 406(6791):5. PubMed ID: 10894508 [No Abstract] [Full Text] [Related]
3. Avoiding legal and ethical pitfalls of industry-sponsored research: the co-existence of research, scholarship, and marketing in the pharmaceutical industry. Dorfman HL; Reig LP Food Drug Law J; 2004; 59(4):595-615. PubMed ID: 15880876 [No Abstract] [Full Text] [Related]
4. Orphan products development and some methods for maximizing the usefulness of research on rare diseases. Finkel MJ Prog Clin Biol Res; 1985; 197():11-8. PubMed ID: 4070285 [No Abstract] [Full Text] [Related]
5. What does R&D really cost? Huff B GMHC Treat Issues; 2001; 15(7-8):1-7. PubMed ID: 11548507 [No Abstract] [Full Text] [Related]
6. Rising costs hold up drug discovery. Miller HI Nature; 1998 Oct; 395(6705):835. PubMed ID: 9804407 [No Abstract] [Full Text] [Related]
7. Excavating treasure from the amber of the prior art: why the public benefit doctrine is ill-suited to the pharmaceutical sciences. Hess RA Food Drug Law J; 2011; 66(1):105-20, iii. PubMed ID: 24505849 [TBL] [Abstract][Full Text] [Related]
8. Is drug research trustworthy? The pharmaceutical industry funnels money to prominent scientists who are doing research that affects its products--and nobody can stop it. Seife C Sci Am; 2012 Dec; 307(6):56-63. PubMed ID: 23230798 [No Abstract] [Full Text] [Related]
9. What's wrong with money in science. Stossel T; Shaywitz D Washington Post; 2006 Jul; ():B3. PubMed ID: 16838447 [No Abstract] [Full Text] [Related]
10. The National Institutes of Health Small Business Innovation Research (SBIR) Program: opportunities for orphan drug development. Engstrom LO Prog Clin Biol Res; 1985; 197():25-30. PubMed ID: 4070295 [No Abstract] [Full Text] [Related]
11. [Research in pharmaceutical industry, the driving energy of development]. Karsenti R Cah Sociol Demogr Med; 1978; 18(2):59-68. PubMed ID: 679061 [No Abstract] [Full Text] [Related]
12. The $2.6 billion pill--methodologic and policy considerations. Avorn J N Engl J Med; 2015 May; 372(20):1877-9. PubMed ID: 25970049 [No Abstract] [Full Text] [Related]
13. Ethics. Senate probe of research psychiatrists. Kaiser J Science; 2009 Jul; 325(5936):30. PubMed ID: 19574367 [No Abstract] [Full Text] [Related]
15. Clinical research: outlook from industry. Echols R Clin Perform Qual Health Care; 1996; 4(2):113-4. PubMed ID: 10156942 [No Abstract] [Full Text] [Related]
19. Comparative effectiveness casts first shadows across US industry. Waltz E Nat Biotechnol; 2009 Mar; 27(3):211-2. PubMed ID: 19270651 [No Abstract] [Full Text] [Related]
20. Advisors may urge NIH to seek out industry support for clinical trials. Appel A Nature; 1995 Nov; 378(6553):116. PubMed ID: 7477301 [No Abstract] [Full Text] [Related] [Next] [New Search]